Purchase Order 75D30120P07522

Award Date 3/9/20
Potential Completion Date 3/23/20
Potential Value $96K
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company, to provide a GridION Mk1 capex sequencing system and associated lab equipment and supplies. The $126,680 contract has a completion date of December 13, 2022 and does not utilize a set-aside designation. Based on previous federal contract awards, Oxford Nanopore Technologies Inc. provides...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
This is a $12,500.00 firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the acquisition of a license and warranty for the GridION device to perform whole genome sequencing (WGS) at the CDC/DGHP laboratory on behalf of the CDC in Thailand. The contract has no set-aside designation. Oxford Nanopore...
This is a $41,180 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the acquisition of MinION MK1C basic starter packs on behalf of the CDC's operations in Thailand. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for DNA, RNA, and protein analysis, and has secured numerous prime federal contracts from...
This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
This federal contract award is for the procurement of lab instrument software from Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $12,500 firm-fixed-price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a completion date of August 31, 2024. Oxford Nanopore Technologies is a provider of next-generation genomic sequencing equipment, consumables, and associated services to various...
This firm fixed-price purchase order, valued at $16,199.00, was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides for the delivery of Oxford Nanopore's VOLTRAX V2 CAPEX equipment, which is part of their nanopore-based electronic systems used for real-time analysis of genetic materials and other biological molecules. The contract has no set-aside designation. Oxford Nanopore...
This federal contract award, valued at $12,500.00, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a GridION software license and device warranty. Oxford Nanopore Technologies specializes in nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins, and has secured numerous federal contracts to supply next-generation...
This is a $95,605 firm-fixed-price purchase order awarded by the Southeast Area office of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the GRIDLON X5-CAPEX genomic sequencing system and related products and services, with an ultimate completion date of October 4, 2019. The contract does not have a set-aside designation. Oxford Nanopore Technologies is a prime federal contractor that has secured numerous awards...

This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables, and associated services to support various government research initiatives, including infectious disease tracking, agricultural genomics, and biomedical studies. This specific contract is for the delivery of the GridION sequencing device, which is part of Oxford Nanopore's innovative nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The parent company, Oxford Nanopore Technologies PLC, has also received a $167,924 purchase order from the CDC for COVID-19 detection products.

Generated 4/2/25, 11:33 PM